Human disease
allergic rhinitis
Mondo defines it as: “Inflammation of the nasal mucous membranes caused by an IgE-mediated response to external allergens. The inflammation may also involve the mucous membranes of the sinuses, eyes, middle ear, and pharynx. Symptoms include sneezing, nasal congestion, rhinorrhea, and itching. It may lead to fatigue, drowsiness, and malaise thus causing impairment of the quality of life.”
1 disease group in OMIA reaches this disease, through OMIA's own Mondo link or its OMIM numbers. The page shows the chain. It does not say whether an animal is a model of this disease.
Animal diseases
By natural-model score for this disease, highest first. The score says how complete and how well supported each chain is, by stated rules. How the score works.
| OMIA group | Name | Found by | Species | The chain reached | Score |
|---|---|---|---|---|---|
| 27 | Allergic rhinitis | The group's name | 1 | Human disease |
31.5
|
Human genes
Each human gene of these disease groups that Open Targets links to this disease.
Open Targets links none of these groups' human genes to this disease.
Drugs tested for this disease
Each ChEMBL drug that has been tested for this disease, and the human genes above it acts on, if any. Open Targets gives some drugs, such as most enzyme replacement therapies, no target gene.
| Drug | Acts on | Latest stage for this disease |
|---|---|---|
| Acrivastine | None of these genes | Approved |
| Astemizole | None of these genes | Approved |
| Atropine | None of these genes | Approved |
| Azatadine | None of these genes | Approved |
| Azelastine | None of these genes | Approved |
| Beclomethasone | None of these genes | Approved |
| Beclomethasone Dipropionate | None of these genes | Approved |
| Bepotastine | None of these genes | Approved |
| Bilastine | None of these genes | Approved |
| Brompheniramine | None of these genes | Approved |
| Budesonide | None of these genes | Approved |
| Cetirizine | None of these genes | Approved |
| Chlorpheniramine | None of these genes | Approved |
| Ciclesonide | None of these genes | Approved |
| Clemastine | None of these genes | Approved |
| Desloratadine | None of these genes | Approved |
| Dexamethasone | None of these genes | Approved |
| Dexamethasone Phosphoric Acid | None of these genes | Approved |
| Diphenhydramine | None of these genes | Approved |
| Diphenylpyraline | None of these genes | Approved |
| Emedastine | None of these genes | Approved |
| Epinastine | None of these genes | Approved |
| Epinephrine | None of these genes | Approved |
| Fexofenadine | None of these genes | Approved |
| Flunisolide | None of these genes | Approved |
| Fluticasone | None of these genes | Approved |
| Fluticasone Furoate | None of these genes | Approved |
| Fluticasone Propionate | None of these genes | Approved |
| Isopropamide | None of these genes | Approved |
| Levocetirizine | None of these genes | Approved |
| Loratadine | None of these genes | Approved |
| Mequitazine | None of these genes | Approved |
| Methdilazine | None of these genes | Approved |
| Methylpromazine | None of these genes | Approved |
| Mizolastine | None of these genes | Approved |
| Mometasone Furoate | None of these genes | Approved |
| Montelukast | None of these genes | Approved |
| Olopatadine | None of these genes | Approved |
| Prednisolone | None of these genes | Approved |
| Prednisolone Phosphoric Acid | None of these genes | Approved |
| Prednisone | None of these genes | Approved |
| Pseudoephedrine | None of these genes | Approved |
| Triamcinolone | None of these genes | Approved |
| Triamcinolone Acetonide | None of these genes | Approved |
| Triprolidine | None of these genes | Approved |
| Betamethasone | None of these genes | Phase 3 |
| Freneslerbart | None of these genes | Phase 3 |
| Glutaral | None of these genes | Phase 3 |
| Mevonlerbart | None of these genes | Phase 3 |
| Mometasone | None of these genes | Phase 3 |
| Phenylephrine | None of these genes | Phase 3 |
| Resveratrol | None of these genes | Phase 3 |
| Ergocalciferol | None of these genes | Phase 2/3 |
| Adc3680 | None of these genes | Phase 2 |
| Aldesleukin | None of these genes | Phase 2 |
| Azd-8848 | None of these genes | Phase 2 |
| Bamirastine | None of these genes | Phase 2 |
| Carbon Dioxide | None of these genes | Phase 2 |
| Denufosol | None of these genes | Phase 2 |
| Ensifentrine | None of these genes | Phase 2 |
| Fevipiprant | None of these genes | Phase 2 |
| Ginger | None of these genes | Phase 2 |
| Gsk-2245035 | None of these genes | Phase 2 |
| Hypromellose | None of these genes | Phase 2 |
| Incomplete Freund'S Adjuvant | None of these genes | Phase 2 |
| Jnj-39220675 | None of these genes | Phase 2 |
| Levocabastine | None of these genes | Phase 2 |
| Mrx-4 | None of these genes | Phase 2 |
| Norketotifen | None of these genes | Phase 2 |
| Omalizumab | None of these genes | Phase 2 |
| Oxymetazoline | None of these genes | Phase 2 |
| Ozureprubart | None of these genes | Phase 2 |
| Pf-03654764 | None of these genes | Phase 2 |
| Qav680 | None of these genes | Phase 2 |
| Qax-576 | None of these genes | Phase 2 |
| Quilizumab | None of these genes | Phase 2 |
| Rofleponide | None of these genes | Phase 2 |
| Sb-705498 | None of these genes | Phase 2 |
| Sodium Chloride | None of these genes | Phase 2 |
| Stapokibart | None of these genes | Phase 2 |
| Sulforaphane | None of these genes | Phase 2 |
| Tetrachlorodecaoxide | None of these genes | Phase 2 |
| Tezepelumab | None of these genes | Phase 2 |
| Theophylline Anhydrous | None of these genes | Phase 2 |
| Timapiprant | None of these genes | Phase 2 |
| Umesolerbart | None of these genes | Phase 2 |
| Ur-63325 | None of these genes | Phase 2 |
| Votucalis | None of these genes | Phase 2 |
| Iodixanol | None of these genes | Phase 1/2 |
| Syrup | None of these genes | Phase 1/2 |
| Cal-263 | None of these genes | Phase 1 |
| Esketamine | None of these genes | Phase 1 |
| Gamma-Tocopherol | None of these genes | Phase 1 |
| Gsk-1004723 | None of these genes | Phase 1 |
| Gw-328267 | None of these genes | Phase 1 |
| Idelalisib | None of these genes | Phase 1 |
| Ketorolac | None of these genes | Phase 1 |
| Oxelumab | None of these genes | Phase 1 |
| Substance P | None of these genes | Phase 1 |
| Betamethasone Phosphoric Acid | None of these genes | Early phase 1 |
| Hydrocortisone | None of these genes | Early phase 1 |
| Methylprednisolone | None of these genes | Early phase 1 |
| R-112 | None of these genes | Investigational new drug |
| Betamethasone Dipropionate | None of these genes | Unknown |
| Cromolyn | None of these genes | Unknown |
| Dupilumab | None of these genes | Unknown |
| Ganciclovir | None of these genes | Unknown |
| Hydrogen | None of these genes | Unknown |
| Methylprednisolone Acetate | None of these genes | Unknown |
| Triamcinolone Hexacetonide | None of these genes | Unknown |
| Umifenovir | None of these genes | Unknown |
The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.